- Report
- February 2024
- 111 Pages
Global
From €4317EUR$4,750USD£3,697GBP
- Report
- February 2024
- 130 Pages
Global
From €4317EUR$4,750USD£3,697GBP
- Report
- February 2024
- 120 Pages
Global
From €4317EUR$4,750USD£3,697GBP
- Report
- February 2024
- 120 Pages
Global
From €4317EUR$4,750USD£3,697GBP
- Report
- August 2022
- 114 Pages
Global
From €4317EUR$4,750USD£3,697GBP
- Report
- June 2023
- 180 Pages
Global
From €4498EUR$4,949USD£3,852GBP
- Report
- February 2024
- 130 Pages
Global
From €4317EUR$4,750USD£3,697GBP
- Report
- April 2023
- 117 Pages
Global
From €4317EUR$4,750USD£3,697GBP
- Report
- August 2022
- 245 Pages
North America
From €3136EUR$3,450USD£2,685GBP
- Report
- January 2024
- 200 Pages
Global
From €3772EUR$4,150USD£3,230GBP
- Report
- August 2023
- 145 Pages
Global
From €2863EUR$3,150USD£2,452GBP
- Report
- October 2021
- 115 Pages
Global
From €4045EUR$4,450USD£3,463GBP
- Report
- April 2020
- 120 Pages
Global
From €3327EUR$3,660USD£2,849GBP
- Report
- March 2024
- 134 Pages
Europe
From €3136EUR$3,450USD£2,685GBP
- Report
- February 2023
- 118 Pages
Global
From €4090EUR$4,500USD£3,502GBP
- Report
- August 2022
- 118 Pages
Global
From €4090EUR$4,500USD£3,502GBP
- Report
- August 2022
- 115 Pages
Global
From €4090EUR$4,500USD£3,502GBP
- Report
- May 2023
- 147 Pages
Global
From €4498EUR$4,949USD£3,852GBP
- Report
- December 2023
- 223 Pages
Global
From €3272EUR$3,600USD£2,802GBP
- Report
- December 2023
- 117 Pages
Asia Pacific
From €1363EUR$1,500USD£1,167GBP

Pneumonia is an infectious disease caused by bacteria, viruses, or fungi that affects the lungs. It is one of the most common infectious diseases and is a leading cause of death worldwide. Infectious disease testing is used to diagnose and monitor the progression of pneumonia. Tests used to diagnose pneumonia include chest X-rays, sputum cultures, and blood tests. Treatment for pneumonia typically involves antibiotics, antivirals, and other medications.
The pneumonia market within the context of infectious disease testing is a rapidly growing market. It is driven by the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis. The market is expected to grow due to the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis.
Some companies in the pneumonia market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more